LOXL2 and carcinoma of esophagus: The LCN2/LOXL2/MMP9 complex remodels the ECM and activates the FAK/AKT/GSK3β signalling pathway to enhance SPOCK1 expression, promoting the migration and invasion of oesophageal cancer cells.